Значимость субклинического гипотиреоза и его заместительной терапии для развития сердечно-сосудистой патологии

Автор: Самитин В.В., Родионова Т.Н.

Журнал: Саратовский научно-медицинский журнал @ssmj

Статья в выпуске: 4 т.4, 2008 года.

Бесплатный доступ

В обзоре представлены современные сведения о влиянии субклинического гипотиреоза на морфологию и функциональное состояние миокарда и артериальных сосудов, а также некоторые классические и «новые» факторы риска атеросклероза. Обсуждается связанный с субклиническим гипотиреозом риск клинически значимых осложнений (сердечно-сосудистых, нарушений гемостаза илипидного обмена), а также данные об эффектах заместительной терапии субклинического гипотиреоза.

Субклинический гипотиреоз, левотироксин, заместительная терапия, сердечно-сосудистый риск

Короткий адрес: https://sciup.org/14916806

IDR: 14916806

Список литературы Значимость субклинического гипотиреоза и его заместительной терапии для развития сердечно-сосудистой патологии

American Association of Clinical Endocrinologists; American Thyroid Association; The Endocrine Society Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society/H. Gharib, R.M. Tuttle, H.J. Baskin et al.//J Clin Endocrinol Metab. -2005. -Vol. 90. -P. 581-585.
Arterial stiffness is increased in subjects with hypothyroidism/A.G. Dagre, J.P. Lekakis, T.G. Papaioannou et al.//Int J Cardiol. -2005. -Vol. 103. -P. 1-6.
Assessment of left ventricular diastolic function by radionuclide ventriculography at rest and exercise in subclinical hypothyroidism, and its response to L-thyroxine therapy/G. Brenta, L.A. Mutti, M. Schnitman et al.//Am J Cardiol. -2003. -Vol. 91. -P. 1327-1330.
Ayala, A.R. When to treat mild hypothyroidism/A.R. Ayala, M.D. Danese, P.W. Ladenson//Endocrinol Metab Clin North Am. -2000. -Vol. 29. -P. 399-415.
Biondi, B. The clinical significance of subclinical thyroid dysfunction/B. Biondi, D. S. Cooper//Endocrine Reviews. -2008 Feb, 29. -P. 76 -131.
Biondi, B. Hypothyroidism as a riskfactorforcardiovascular disease/B. Biondi, I. Klein//Endocrine. -2004. -Vol. 24. -P. 1-13. 74
Cappola, A.R. Hypothyroidism and atherosclerosis/A.R. Cappola, P.W. Ladenson//J Clin Endocrinol Metab. -2003. -Vol. 88. -P. 2438-44.
Caraccio, N. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study/N. Caraccio, E. Ferranini, F. Monzani//J Clin Endocrinol Metab. -2002. -Vol. 87. -P. 1533-1538.
Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism/R. Chadarevian, E. Bruckert, L. Leenhardtet al.//J Clin Endocrinol Metab. -2001. -Vol. 86. -P. 732-737.
Cooper, D.S. Clinical practice. Subclinical hypothyroidism/D.S. Cooper//N Engl J Med. -2001. -Vol. 345. -P. 260-265.
Danzi, S. Thyroid hormone and blood pressure regulation/S. Danzi, I. Klein//Curr Hypertens. -2003. -P.513-520.
Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study/A. Ripoli, A. Pingitore, B. Favilli et al.//J Am Coll Cardiol. -2005. -Vol. 45. -P. 439-445.
Double-blind cross-over 12-month study of L-thyroxine treatment of women with 'subclinical' hypothyroidism/E. Nystrom, K. Caidahl, G. Fager et al.//Clin Endocrinol (Oxf). -1988. -Vol. 29. -P. 63-67.
Duntas, L.H. Circulating levels of oxidized lowdensity lipoprotein in overt and mild hypothyroidism/L.H. Duntas, E. Mantzou, D.A. Koutras//Thyroid. -2002. -Vol. 12. -P. 1003-1007.
Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism/F. Aghini-Lombardi, V. Di Bello, E. Talini, A. Di Cori et al.//Eur J Endocrinol. -2006, Jul;1 55(1). P.3-9.
Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study/F. Monzani, V. Di Bello, N. Caraccio et al.//J Clin Endocrinol Metab. -2001. -Vol. 86. -P. 1110-1115.
Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo-controlled study/F. Monzani, N. Caraccio, M. Kozakowa et al.//J Clin Endocrinol Metab. -2004. -Vol. 89. -P. 2099-2106.
Effects of Thyroid Hormone on the Cardiovascular System/S. Fazio, E.A. Palmieri, G. Lombardi, B. Biondi//Recent Prog Horm Res. -2004. -Vol. 59. -P. 31 -50.
Effects of thyroxin therapy on cardiac function in patients with subclinical hypothyroidism: index of myocardial performance in the evaluation of left ventricular function/M. Yazici, S. Gorgulu, y. Sertbas et al.//Int J Cardiol. -2004. -Vol. 95. -P. 135-143.
Global fibrinolytic capacity in patients with subclinical hypothyroidism/S. Guldiken, M. Demir, B. Turgut et al.//Endocr J. -2005. -Vol. 52. -P. 363-367.
Guidelines Committee, National Academy of Clinical Biochemistry Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease/Z. Baloch, P. Carayon, B. Conte-Devolx et al.//Thyroid. -2003. -Vol. 13. -P. 123-126.
Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism/J. Faber, L. Petersen, N. Wiinberg et al.//Thyroid. -2002. -Vol. 12. -P. 319-324.
Hueston, W.J. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism/W.J. Hueston, D.E. King, M.E. Geesey//Clin Endocrinol (Oxf). -2005. -Vol. 63. -P. 582-587.
Hueston, W.J. Subclinical hypothyroidism and the risk of hypercholesterolemia/W.J. Hueston, W.S. Pearson//Ann Fam Med. -2004. -Vol. 2. -P. 351-355.
Hypothyroidism and the heart. Examination of left ventricular function in subclinical hypothyroidism/J. Foldes, M. Istvanfy, H. Halmagyi et al.//Acta Med Hung. -1987. -Vol. 44. -P. 337-347.
Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy/S. Taddei, N. Caraccio, A. Virdis et al.//J Clin Endocrinol Metab. -2003. -Vol. 88. -P. 3731-3737.
Increased pulse wave velocity in subclinical hypothyroidism/T. Nagasaki, M. Inaba, Y. Kumeda et al.//J Clin Endocrinol Metab. -2006. -Vol. 91. -P. 154-158.
Is there a need to redefine the upper normal limit of TSH?/G. Brabant, P. Beck-Peccoz, B. Jarzab et al.//Eur J Endocrinol. -2006. -Vol. 154. -P. 633-637.
Klein, I. Thyroid hormone. Targeting the vascular smooth muscle cell/I. Klein, K. Ojamaa//Circ Res. -2001. -Vol. 88. -P. 260-261.
Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a newultrasound tool: pulsed tissue Doppler/G. Vitale, M. Galderisi, G.A. Lupoli et al.//J Clin Endocrinol Metab. -2002. -Vol. 87. -P. 4350-4355.
Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial?/Z. Efstathiadou, S. Bitsis, H.J. Milionis et al.//Eur J Endocrinol. -2001. -Vol. 145. -P. 705-710.
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure/W.M. Tunbridge, D.C. Evered, R. Hall et al.//Clin Endocrinol. -1977. -Vol.7. -P. 495-508.
Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues/J.J. Staub, B.U. Althaus, H. Engler et al.//Am J Med. -1992. -Vol. 92. -P. 631-642.
Subclinical hyperthyroidism: clinical features and treatment options/B. Biondi, E.A. Palmieri, M. Klain et al.//Eur J Endocrinol. -2005. -Vol. 152. -P. 1-9.
Subclinical hypothyroidism and cardiac function/B. Biondi, E.A. Palmieri, G. Lombardi, S. Fazio//Thyroid. -2002. -Vol. 12. -P. 505-510.
Subclinical hypothyroidism, arterial stiffness and myocardial reserve/P.J.D. Owen, C. Rajiv, D. Vinereanu etal.//J Clin Endocrinol Metab. -2006. -Vol. 9. -P. 2126-2132.
Subclinical hypothyroidism in a biethnic, urban community/R.D. Lindeman, D.S. Schade, A. LaRue et al.//J Am Geriatr Soc. -1999. -Vol. 47. -P. 703-709.
Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years/J. Kvetny, P.E. Heldgaard, E.M. Bladbjerg, J. Gram//Clin Endocrinol (Oxf). -2004. -Vol. 61. -P. 232-238.
Subclinical hypothyroidism may be associated with elevated high-sensitive C-reactive protein (low grade inflammation) and fasting hyperinsulinemia/A. Tuzcu, M. Bahceci, D. Gokalp et al.//Endocr J. -2005. -Vol. 52. -P. 89-94.
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management/M.I. Surks, E. Ortiz, G.H. Daniels et al.//JAMA -2004. -Vol. 291. -P. 228-238.
The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function and quality of life in subclinical hypothyroidism: randomised, crossover trial/S. Razvi, L. Ingoe, G. Keeka etal.//J Clin Endocrinol Metab. -2007. -Vol. 92. -P. 1715-23.
The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic/V. Tsimihodimos, E. Bairaktari, С Tzallas et al.//Thyroid. -1999. -Vol. 9. -P. 365-368.
The prevalence of subclinical hypothyroidism at different total plasma cholesterol levels in middle aged men and women: a need for case-finding?/A.J. Bindels, R.G. Westendorp, M. Frolich et al.//Clin Endocrinol. -1999. -Vol. 50. -P. 217-220.
Thyroid dysfunction and serum lipids: a community-based study/J.P. Walsh, A.P. Bremner, M.K. Bulsara et al.//Clin Endocrinol (Oxf). -2005. -Vol. 63. -P. 670-675.
Thyroid hormone replacement for subclinical hypothyroidism/H.C. Villar, H. Saconato, O. Valente, A.N. Atallah//Cochrane Database Syst Rev. -2007;(3):CD003419.
Wartofsky, L. The evidence for a narrower thyrotropin reference range is compelling/L. Wartofsky, R.A. Dickey//J Clin Endocrinol Metab. -2005. -Vol. 90. -P. 5483-5488.
Zile, M.R. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment/M.R. Zile, D.L. Brutsaert//Circulation. -2002. -26;105:1503-8.

Еще

Статья обзорная